These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 31278799)

  • 1. Lack of an effective drug therapy for abdominal aortic aneurysm.
    Golledge J; Moxon JV; Singh TP; Bown MJ; Mani K; Wanhainen A
    J Intern Med; 2020 Jul; 288(1):6-22. PubMed ID: 31278799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis and management of abdominal aortic aneurysm.
    Golledge J; Thanigaimani S; Powell JT; Tsao PS
    Eur Heart J; 2023 Aug; 44(29):2682-2697. PubMed ID: 37387260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of blood pressure lowering drugs and antibiotics on abdominal aortic aneurysm growth: a systematic review and meta-analysis.
    Golledge J; Singh TP
    Heart; 2021 Sep; 107(18):1465-1471. PubMed ID: 33199361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Theories and Clinical Trial Evidence for Limiting Human Abdominal Aortic Aneurysm Growth.
    Yu J; Liu S; Huang J; Wang W
    Curr Drug Targets; 2018; 19(11):1302-1308. PubMed ID: 29141546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abdominal aortic aneurysm: update on pathogenesis and medical treatments.
    Golledge J
    Nat Rev Cardiol; 2019 Apr; 16(4):225-242. PubMed ID: 30443031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic and Therapeutic Significance of Angiotensin II Type I Receptor in Abdominal Aortic Aneurysms.
    Xu B; Xuan H; Iida Y; Miyata M; Dalman RL
    Curr Drug Targets; 2018; 19(11):1318-1326. PubMed ID: 29359665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin-angiotensin system blockade does not attenuate abdominal aortic aneurysm growth, rupture rate, or perioperative mortality after elective repair.
    Salata K; Syed M; Hussain MA; Eikelboom R; de Mestral C; Verma S; Al-Omran M
    J Vasc Surg; 2018 Feb; 67(2):629-636.e2. PubMed ID: 29175038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical management of abdominal aortic aneurysms.
    Weiss N; Rodionov RN; Mahlmann A
    Vasa; 2014 Nov; 43(6):415-21. PubMed ID: 25339159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal Time for Pharmacological Treatment of Abdominal Aortic Aneurysm.
    Iida Y; Sawa S; Shimizu H
    Curr Drug Targets; 2018; 19(11):1297-1301. PubMed ID: 29284387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic therapy in abdominal aortic aneurysm: beneficial or detrimental?
    Cameron SJ; Russell HM; Owens AP
    Blood; 2018 Dec; 132(25):2619-2628. PubMed ID: 30228233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Status and Perspectives on Pharmacologic Therapy for Abdominal Aortic Aneurysm.
    Yoshimura K; Morikage N; Nishino-Fujimoto S; Furutani A; Shirasawa B; Hamano K
    Curr Drug Targets; 2018; 19(11):1265-1275. PubMed ID: 29284386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol for the Metformin Aneurysm Trial (MAT): a placebo-controlled randomised trial testing whether metformin reduces the risk of serious complications of abdominal aortic aneurysm.
    Golledge J; Arnott C; Moxon J; Monaghan H; Norman R; Morris D; Li Q; Jones G; Roake J; Bown M; Neal B
    Trials; 2021 Dec; 22(1):962. PubMed ID: 34961561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical treatment of small abdominal aortic aneurysm.
    Assar AN
    J Cardiovasc Surg (Torino); 2012 Aug; 53(4):517-25. PubMed ID: 22854530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial.
    Thompson RW; Baxter BT
    Ann N Y Acad Sci; 1999 Jun; 878():159-78. PubMed ID: 10415728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of statins on the expansion rate and rupture risk of abdominal aortic aneurysms.
    VAN KUIJK JP; FLU WJ; WITTEVEEN OP; VOUTE M; BAX JJ; POLDERMANS D
    J Cardiovasc Surg (Torino); 2009 Oct; 50(5):599-609. PubMed ID: 19741575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth predictors and prognosis of small abdominal aortic aneurysms.
    Schlösser FJ; Tangelder MJ; Verhagen HJ; van der Heijden GJ; Muhs BE; van der Graaf Y; Moll FL;
    J Vasc Surg; 2008 Jun; 47(6):1127-33. PubMed ID: 18440183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardization of outcome measures in clinical trials of pharmacological treatment for abdominal aortic aneurysm.
    Wang XL; Thompson MM; Dole WP; Dalman RL; Zalewski A
    Expert Rev Cardiovasc Ther; 2012 Oct; 10(10):1251-60. PubMed ID: 23113642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical management of small abdominal aortic aneurysms.
    Baxter BT; Terrin MC; Dalman RL
    Circulation; 2008 Apr; 117(14):1883-9. PubMed ID: 18391122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological Therapy of Abdominal Aortic Aneurysm: An Update.
    Wang YD; Liu ZJ; Ren J; Xiang MX
    Curr Vasc Pharmacol; 2018 Jan; 16(2):114-124. PubMed ID: 28412911
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.